药物治疗是预防冠状动脉内介入治疗后再狭窄的最直接、最简便的方法。
Drug therapy is a most direct and convenient method for prevention of restenosis after percutaneous coronary intervention.
结论EGB对于动脉粥样硬化形成及经皮腔内冠状动脉介入治疗后再狭窄的防治可能具有应用前景。
CONCLUSION EGB may have some potential clinical implication in the prevention and treatment of atherosclerosis and restenosis after percutaneous transluminal coronary angioplasty.
随着对冠状动脉介入治疗后再狭窄机理研究的进展和涂层支架技术的研发成功，使药物涂层支架预防再狭窄成为可能。
With the progress of studying restenosis mechanism after coronary interventions therapy and successness of coated stent technology, it is possible to prevent from the restenosis by coated stents.
安放支架后再狭窄的治疗可应用球囊扩张、旋切术、旋磨术、切割球囊、再次安放支架和放射治疗。
The treatment of in stent restenosis includes balloon dilation, directional atherectomy, rotational atherectomy, cutting balloon, additional stent and radiation therapy.
目的评价兔髂动脉内近距离治疗预防经皮经腔血管成形术（PTA）后再狭窄的可行性及作用。
Objective To evaluate the role of intra arterial brachytherapy to prevent the iliac artery restenosis in the rabbit following percutaneous transluminal angioplasty (PTA).
P 27蛋白的高表达可显著抑制血管平滑肌细胞增殖，有望成为治疗PT CA后再狭窄的新手段。
P27Kipl restrains the proliferation of VSMC obviously and is prospective to become a new means to cure restenosis after PTCA.
目的探讨多巴酚丁胺负荷超声心动图(DSE)评价经皮冠状动脉介入治疗(pci)后再狭窄的准确性和可行性。
Objective To determine the accuracy and usefulness of dobutamine stress echocardiography (DSE) in detecting restenosis after percutaneous coronary intervention (PCI).
方法：收集冠状动脉介入治疗后造影复查再狭窄患者121例，共159处病变，进行再狭窄形式分析。
Methods: 121 Patients with 159 restenosis lesions after intracoronary interventional therapy were included in this study. Restenosis morphology of different kinds of stents were analysed.
方法：收集冠状动脉介入治疗后造影复查再狭窄患者121例，共159处病变，进行再狭窄形式分析。
Methods: 121 Patients with 159 restenosis lesions after intracoronary interventional therapy were included in this study. Restenosis morphology of different kinds of stents were analysed.
应用推荐